1.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000507615, P30CA015083, MC0671, 06-004440, MAYO-MC0671, MAYO-06-004440, NCT00390299
|
2.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000515008, P30CA015083, MC0117, 1260-03, NCI-2009-01199, MAYO-MC0117, NCT00408590
|